The clinical benefit of moisturizers

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 6, 2005, Pages 672-688

  Loden M ^a,b  

^a ACO Hud AB   (Sweden)

^b Box 622 ^*  (Sweden)

Author keywords

Botanicals; Dryness; Emulsifiers; Humectants; Inflammatory disorders; Lipids; Skin permeability

Indexed keywords

CERAMIDE; CHOLESTEROL; EMOLLIENT AGENT; EMULSIFYING AGENT; ESTER; FATTY ACID; GLYCEROL; HERBACEOUS AGENT; HUMECTANT; ICOSAPENTAENOIC ACID; LANOLIN; LINOLEIC ACID; MINERAL OIL; OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PRESERVATIVE; PRIMROSE OIL; PROPYLENE GLYCOL; SALICYLIC ACID; SILICONE OIL; SUNFLOWER OIL; TRIACYLGLYCEROL; UNINDEXED DRUG; VEGETABLE OIL; WATER; WATER OIL CREAM; WAX;

ATOPIC DERMATITIS; BURN; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT ALLERGY; CONTACT DERMATITIS; DOSE RESPONSE; DRUG FORMULATION; DRY SKIN; ECZEMA; HUMAN; HUMIDIFIER; LAMELLAR ICHTHYOSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

ADMINISTRATION, TOPICAL; EMOLLIENTS; HUMANS; ICHTHYOSIS; SKIN ABSORPTION; SKIN CARE; SKIN PHYSIOLOGY; WATER LOSS, INSENSIBLE;

EID: 28544442110     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01326.x     Document Type: Review

References (172)

1. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 1999; 10: 119-126.
2. Lodén M, Maibach HI. Dry Skin and Moisturizers; Chemistry and Function, 1st edn. CRC Press, Boca Raton, 2000.
3. Cork MJ, Britton J, Butler L et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003; 149: 582-589.
4. Hill S, Edwards C. A comparison of the effects of bath additives on the barrier function of skin in normal volunteer subjects. J Dermatolog Treat 2002; 13: 15-18.
5. Stender IM, Blichmann C, Serup J. Effects of oil and water baths on the hydration state of the epidermis. Clin Exp Dermatol 1990; 15: 206-209.
6. Stanfield JW, Levy J, Kyriakopoulos AA et al. A new technique for evaluating bath oil in the treatment of dry skin. Cutis 1981; 28: 458-460.
7. Pepe RC, Wenninger JA. International Cosmetic Ingredient Dictionary and Handbook. The Cosmetic, Toiletry, and Fragrance Association, Washington, 2002.
8. Rhodes LE. Essential fatty acids. In: Dry Skin and Moisturizers: Chemistry and Function. CRC Press, Boca Raton, 2000: 311-325.
9. Miller CC, Tang W, Ziboh VA et al. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. J Invest Dermatol 1991; 96: 98-103.
10. Schurer NY. Implementation of fatty acid carriers to skin irritation and the epidermal barrier. Contact Dermatitis 2002; 47: 199-205.
11. Sheu MY, Fowler AJ, Kao J et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118: 94-101.
12. Fowler AJ, Sheu MY, Schmuth M et al. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 2003; 120: 246-255.
13. Lodén M, Andersson AC. Effect of topically applied lipids on surfactant-irritated skin. Br J Dermatol 1996; 134: 215-220.
14. Komuves LG, Hanley K, Jiang Y et al. Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 1998; 111: 429-433.
15. Wright S, Burton JL. Oral evening-primrose-seed oil improves atopic eczema. Lancet 1982; 2: 1120-1122.
16. Bamford JTM, Gibson RW, Renier CM. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol 1985; 13: 959-965.
17. Henz BM, Jablonska S, van de Kerkhof PCM et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic dermatitis. Br J Dermatol 1999; 140: 685-688.
18. Hederos CA, Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996; 75: 494-497.
19. Escobar So, Achenbach R, Innantuono R et al. Topical fish oil in psoriasis - a controlled and blind study. Clin Exp Dermatol 1992; 17: 159-162.
20. Dewsbury CE, Graham P, Darley CR. Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis. Br J Dermatol 1989; 120: 581.
21. Gupta AK, Ellis CN, Goldfarb MT et al. The role of fish oil in psoriasis. A randomized, double bund, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis. Int J Dermatol 1990; 29: 591-595.
22. Zepelin HHH-V, Mrowietz U, Färber L et al. Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study. Br J Dermatol 1993; 129: 713-717.
23. Hartop PJ, Allenby CF, Prottey C. Comparison of barrier function and lipids in psoriasis and essential fatty acid-deficient rats. Clin Exp Dermatol 1978; 3: 259-267.
24. Kibbe AW. Handbook of Pharmaceutical Excipients, 3rd edn. American Pharmaceutical Association, Pharmaceutical Press, Washington, London, 2000.
25. Barany E, Lindberg M, Lodén M. Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm 2000; 195: 189-195.
26. Imokawa G, Akasaki S, Hattori M et al. Selective recovery of deranged water-holding properties by stratum corneum lipids. J Invest Dermatol 1986; 87: 758-761.
27. Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated in urine skin. Arch Dermatol 1993; 129: 728-738.
28. Rawlings AV, Harding C, Watkinson A et al. The effect of glycerol and humidity on desmosome degradation in stratum corneum. Arch Dermatol Res 1995; 287: 457-464.
29. Froebe CL, Simion FA, Ohlmeyer H et al. Prevention of stratum corneum lipid phase transitions in vitro by glycerol - An alternative mechanism for skin moisturization. J Soc Cosmet Chem 1990; 41: 51-65.
30. Mattai J, Froebe CL, Rhein LD et al. Prevention of model stratum corneum lipid phase transitions in vitro by cosmetic additives - Differential scanning calorimetry, optical microscopy, and water evaporation studies. J Soc Cosmet Chem 1993; 44: 89-100.
31. Fluhr JW, Mao-Qiang M, Brown BE et al. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol 2003; 120: 728-737.
32. Schmid-Grendelmeier P, Wyss M, Elsner P. Contact allergy to dexpanthenol. A report of seven cases and review of the literature. Dermatosen 1995; 43: 175-178.
33. Reynolds JEF. Martindale the Extra Pharmacopoeia, 30th edn. The Pharmaceutical Press, London, 1993.
34. Final Report on the safety assessment of panthenol and pantothenic acid. J Am Coll Toxicol 1987; 6: 139-163.
35. Laden K. Natural moisturization factors in skin. Am Perfum Cosmet 1967; 82: 77-79.
36. Jacobi OK. Moisture regulation in the skin. Drug Cosmet Ind 1959; 84: 732-812.
37. Middleton J. Development of a skin cream designed to reduce dry and flaky skin. J Soc Cosmet Chem 1974; 25: 519-534.
38. Wehr R, Krochmal L, Bagatell F et al. A controlled two-center study of lactate 12% lotion and a petrolatum-based creme in patients with xerosis. Cutis 1986; 37: 205-209.
39. Swanbeck G, Rajka G. Antipruritic effect of urea solutions. Acta Derm Venereol 1970; 50: 225-227.
40. Rosten M. The treatment of ichthyosis and hyperkeratotic conditions with urea. Aust J Dermatol 1970; 11: 142-144.
41. Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol Ther 2003; 16: 106-113.
42. Shelton RM. Aloe vera. Its chemical and therapeutic properties. Int J Dermatol 1991; 30: 679-683.
43. Andreassi M, Stanghellini E, Ettorre A et al. Antioxidant activity of topically applied lycopene. J Eur Acad Dermatol Venereol 2004; 18: 52-55.
44. Lundstrom A, Egelrud T. Cell shedding from human plantar skin in vitro: evidence of its dependence on endogenous proteolysis. J Invest Dermatol 1988; 91: 340-343.
45. Denda M, Katagiri C, Hirao T et al. Some magnesium salts and a mixture of magnesium and calcium salts accelerate skin barrier recovery. Arch Dermatol Res 1999; 291: 560-563.
46. Ashida Y, Ogo M, Denda M. Epidermal interleukin-1 alpha generation is amplified at low humidity: implications for the pathogenesis of inflammatory dermatoses. Br J Dermatol 2001; 144: 238-243.
47. Morris-Jones R, Robertson SJ, Ross JS et al. Dermatitis caused by physical irritants. Br J Dermatol 2002; 147: 270-275.
48. Cork MJ. The role of Staphylococcus aureus in atopic eczema: treatment strategies. J Eur Acad Dermatol Venereol 1996; 7: S31-S37.
49. Strange P, Skov L, Lisby S et al. Staphylococal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132: 27-33.
50. Ghadially R, Brown BE, Hanley K et al. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol 1996; 106: 1064-1069.
51. Garg A, Chren MM, Sands LP et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 2001; 137: 53-59.
52. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985; 65: 102-105.
53. Lodén M, Olsson H, Axell T et al. Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. Br J Dermatol 1992; 126: 137-141.
54. Thune P. Evaluation of the hydration and the water-holding capacity in atopic skin and so-called dry skin. 1989; 144: 133-135.
55. Finlay AY, Nicholls S, King CS et al. The 'dry' non-eczematous skin associated with atopic eczema. Br J Dermatol 1980; 103: 249-256.
56. Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107: 558-564.
57. Motta S, Monti M, Sesana S et al. Abnormality of water barrier function in psoriasis. Arch Dermatol 1994; 130: 452-456.
58. Elias PM, Schmuth M, Uchida Y et al. Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol 2002; 11: 248-256.
59. Lavrijsen AP, Oestmann E, Hermans J et al. Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol 1993; 129: 547-553.
60. Lavrijsen AP, Bouwstra JA, Gooris GS et al. Reduced skin barrier function parallels abnormal stratum corneum lipid organization in patients with lamellar ichthyosis. J Invest Dermatol 1995; 105: 619-624.
61. Gånemo A, Virtanen M, Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double blind study of four different cream formulations. Br J Dermatol 1999; 141: 1027-1032.
62. Grice K, Sattar H, Baker H. Urea and retinoic acid in ichthyosis and their effect on transepidermal water loss and water holding capacity of stratum corneum. Acta Derm Venereal 1973; 54: 114-118.
63. Leveque JLGL, Grove GL, de Rigal J et al. Biophysical characterization of dry facial skin. J Soc Cosmet Chem 1987; 82: 171-177.
64. Linde YW. 'Dry' skin in atopic dermatitis. A clinical study. Acta Derm Venereol 1989; 69: 311-314.
65. Ginsburg IH. The psychosocial impact of skin disease. An overview. Dermatol Clin 1996; 14: 473-484.
66. Serup J. EEMCO guidance for the clinical assessment of dry skin (xerosis) and ichthyosis: clinical scoring systems. Skin Res Technol 1995; 1: 109-114.
67. Zachariae R, Zachariae H, Blomqvist K et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-1016.
68. Kolbe L. Non-invasive methods for testing of the stratum corneum barrier function. In: Lodén M, Maibach HI, eds. Dry Skin and Moisturizers: Chemistry and Function. CRC Press, Boca Raton, 2000: 393-401.
69. Takenouchi M, Suzuki H, Tagami H. Hydration characteristics of pathologic stratum corneum-evaluation of bound water. J Invest Dermatol 1986; 87: 574-576.
70. Elias PM. Lipids and the epidermal permeability barrier. Arch Dermatol Res 1981; 270: 95-117.
71. Anderson RL, Cassidy JM, Hansen JR et al. Hydration of stratum corneum. Biopolymers 1973; 12: 2789-2802.
72. Blank IH. Further observations on factors which influence the water content of the stratum corneum. J Invest Dermatol 1953; 21: 259-271.
73. Laden K, Spitzer R. Identification of a natural moisturizing agent in skin. J Soc Cosm Chem 1967; 18: 351-360.
74. Imokawa G, Kuno H, Kawai M. Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol 1991; 96: 845-851.
75. Jokura Y, Ishikawa S, Yamasaki S et al. Solid state 13C-NMR studies on elastic property of the stratum corneum. 1992; 2: 715.
76. Horii I, Nakayama Y, Obata M et al. Stratum corneum hydration and amino acid content in xerotic skin. Br J Dermatol 1989; 121: 587-592.
77. Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a detect in filaggrin synthesis correlated with an absence of keratohyaline granules. J Invest Dermatol 1985; 84: 191-194.
78. Marstein S, Jellum E, Eldjarn L. The concentration of pyroglutamic acid (2-pyrrolidone-5-carboxylic acid) in normal and psoriatic epidermis, determined on a microgram scale by gas chromatography. Clinica Chim Acta 1973; 43: 389-395.
79. Vahlquist A. Ichthyosis -an inborn dryness of the skin. In: Lodén M, Maibach HI, eds. Dry Skin and Moisturizers; Chemistry and Function. CRC Press, Boca Raton, 2000: 121-133.
80. Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986; 115: 84-92.
81. Williams H. Dowling oration 2001. Evidence-based dermatology - a bridge too far? Clin Exp Dermatol 2001; 26: 714-724.
82. Lodén M. The increase in skin hydration after application of emollients with different amounts of lipids. Acta Derm Venereol 1992; 72: 327-330.
83. Nicholls S, King CS, Marks R. Short term effects of emollients and a bath oil on the stratum corneum. J Soc Cosmet Chem 1978; 29: 617-624.
84. Garber CA, Nightingale CT. Characterizing cosmetic effects and skin morphology by scanning electron microscopy. J Soc Cosmet Chem 1976; 27: 509-531.
85. Jemec GB, Wulf HC. Correlation between the greasiness and the plasticizing effect of moisturizers. Acta Derm Venereol 1999; 79: 115-117.
86. Suzuki Y, Nomura J, Koyama J et al. The role of proteases in stratum corneum: Involvement in stratum corneum desquamation. Arch Dermatol Res 1994; 286: 249-253.
87. Ohman H, Vahlquist A. The pH gradient over the stratum corneum differs in X-linked recessive and autosomal dominant ichthyosis: a clue to the molecular origin of the 'acid skin mantle'? J Invest Dermatol 1998; 111: 674-677.
88. Lodén M. Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 1996; 288: 103-107.
89. Lodén M, Andersson A-C, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm®). Br J Dermatol 1999; 140: 264-267.
90. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24: 1-26.
91. Lucky AW, Leach AD, Laskarzewski P et al. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321-324.
92. Proksch E, Feingold KR, Man MQ et al. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991; 87: 1668-1673.
93. Denda M, Wood LC, Emami S et al. The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 1996; 288: 230-238.
94. Wood LC, Jackson SM, Elias PM et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482-487.
95. Van Scott EJ, Yu RJ. Control of keratinization with alpha-hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders. Arch Dermatol 1974; 110: 586-590.
96. Pope FM, Rees JK, Wells RS et al. Out-patient treatment of ichthyosis: a double-blind trial of ointments. Br J Dermatol 1972; 86: 291-296.
97. Middleton JD, Roberts ME. Effect of a skin cream containing the sodium salt of pyrrolidone carboxylic acid on dry and flaky skin. J Soc Cosmet Chem 1978; 29: 201-205.
98. Frithz A. Investigation of Cortesal®, a hydrocortisone cream and its water-retaining cream base in the treatment of xerotic skin and dry eczemas. Curr Ther Res 1983; 33: 930-935.
99. Dahl MV, Dahl AC. 12% lactate lotion for the treatment of xerosis. Arch Dermatol 1983; 119: 27-30.
100. Lodén M, Andersson AC, Anderson C et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002; 82: 45-47.
101. Kuster W, Bohnsack K, Rippke F et al. Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 1998; 196: 217-222.
102. Pigatto PD, Bigardi AS, Cannistraci C et al. 10% urea cream (Laceran) for atopic dermatitis: a clinical and laboratory evaluation. J Dermatol Treatment 1996; 7: 171-175.
103. Vilaplana J, Coll J, Trullás C et al. Clinical and non-invasive evaluation of 12% ammonium lactate emulsion for the treatment of dry skin in atopic and non-atopic subjects. Acta Derm Venereol 1992; 72: 28-33.
104. Kolbe L, Kligman AM, Stoudemayer T. Objective bioengineering methods to assess the effects of moisturizers on xerotic leg of elderly people. J Dermatol Treat 2000; 11: 241-245.
105. Andersson A-C, Lindberg M, Lodén M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation. J Dermatol Treat 1999; 10: 165-169.
106. Lodén M, Andersson AC, Andersson C et al. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol 2001; 7: 209-213.
107. Serup J. A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme. Acta Derm Venereol Suppl 1992; 177: 34-43.
108. Proksch E, Nissen HP. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. J Dermatol Treat 2002; 13: 173-178.
109. Fluhr JW, Gloor M, Lehmann L et al. Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol 1999; 79: 418-421.
110. Mauro T, Holleran WM, Grayson S et al. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998; 290: 215-222.
111. Buraczewska I, Lodén M. Treatment of surfactant-damaged skin in humans with creams of different pH. Pharmacology 2004.
112. Lodén M, Lindberg M. The influence of a single application of different moisturizers on the skin capacitance. Acta Derm Venereol 1991; 71: 79-82.
113. Wertz PW, Downing DT. Metabolism of topically applied fatty acid methyl esters in BALB/C mouse epidermis. J Dermatol Sci 1990; 1: 33-38.
114. Moloney SJ. The in vitro percutaneous absorption of glycerol trioleate through hairless mouse skin. J Pharm Pharmacol 1988; 40: 819-821.
115. Rawlings AV, Scott IR, Harding CR et al. Stratum corneum moisturization at the molecular level. J Invest Dermatol 1995; 103: 731-740.
116. Tollesson A, Frithz A. Borage oil, an effective new treatment for infantile seborrhoeic dermatitis. Br J Dermatol 1993; 129: 95.
117. Feingold KR, Brown BE, Lear SR et al. Effect of essential fatty acid deficiency on cutaneous sterol synthesis. J Invest Dermatol 1986; 87: 588-591.
118. Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001; 44: 229-234.
119. Loden M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997; 36: 256-260.
120. Kucharekova M, Schalkwijk J, Van de Kerkhof PCM et al. Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction. Contact Dermatitis 2002; 46: 331-338.
121. Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 1992; 26: 387-396.
122. Lodén M, Barany E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm Venereol 2000; 80: 412-415.
123. Mortz CG, Andersen KE, Halkier-Sørensen L. The efficacy of different moisturizers on barrier recovery in hairless mice evaluated by non-invasive bioengineering methods. A model to select the potentially most effective product. Contact Dermatitis 1997; 36: 297-310.
124. Thornfeldt C. Critical and optimal molar ratios of key lipids. In: Lodeøn M, Maibach HI, eds. Dry Skin and Moisturizers: Chemistry and Function. CRC Press, Boca Raton, 2000: 337-347.
125. Mao-Qiang M, Brown BE, Wu-Pong S et al. Exogenous nonphysiologic vs. physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995; 131: 809-816.
126. Zettersten EM, Ghadially R, Feingold KR et al. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol 1997; 37: 403-408.
127. Tollesson A, Frithz A. Transepidermal water loss and water content in the stratum corneum in infantile seborrhoeic dermatitis. Acta Derm Venereol 1993; 73: 18-20.
128. Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47: 198-208.
129. Halkier-Sorensen L, Thestrup-Pedersen K. The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Dermatitis 1993; 29: 266-271.
130. Tabata N, O'Goshi K, Zhen YX et al. Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology 2000; 200: 308-313.
131. Burr S. Emollients for managing dry skin conditions. Prof Nurse 1999; 15: 43-48.
132. Holden C, English J, Hoare C et al. Advised best practice for the use of emollients in eczema and other dry skin conditions. J Dermatolog Treat 2002; 13: 103-106.
133. Held E, Sveinsdottir S, Agner T. Effect of long-term use of moisturizers on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 1999; 79: 49-51.
134. Lodén M, Wessman C. The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int J Cosmet Sci 2001; 23: 115-120.
135. Duval D, Lindberg M, Boman A et al. Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow. Skin Res Technol 2002; 8: 1-5.
136. Hachem JP, De Paepe K, Vanpée E et al. The effect of two of moisturisers on skin barrier damage in allergic contact dermatitis. Eur J Dermatol 2002; 12: 136-138.
137. Berardesca E, Distante F, Vignoli GP et al. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 1997; 137: 934-938.
138. Rawlings AV, Davies A, Carlomusto M et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 1996; 288: 383-390.
139. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung 2000; 50: 659-663.
140. Yunginger JW, Calobrisi SD. Investigation of the allergenicity of a refined peanut oil-containing topical dermatologic agent in persons who are sensitive to peanuts. Cutis 2001; 68: 153-155.
141. Cawley EP, Peterson NT, Wheeler CE. Salicylic acid poisoning in dermatological therapy. JAMA 1953; 151: 372-373.
142. Drugs AAoP-Co. 'Inactive' ingredients in pharmaceutical products: update (subject review). Pediatrics 1997; 99: 268-278.
143. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000; 143: 923-929.
144. De Groot AC, Nater JP, Lende R et al. Adverse effects of cosmetics and toiletries: a retrospective study in the general population. Int J Dermatol Sci 1988; 9: 255-259.
145. Rietschel RL, Fowler JF. Fisher's Contact Dermatitis, 4th edn. Williams & Wilkins, Baltimore, 1995.
146. Ya-Xian Z, Suetake T, Tagami H. Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res 1999; 291: 555-559.
147. Frosch PJ, Kligman AM. A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chem 1977; 28: 197-209.
148. Gabard B, Nook T, Muller KH. Tolerance of the lesioned skin to dermatological formulations. J Appl Cosmetol 1991; 9: 25-30.
149. Larmi E, Lahti A, Hannuksela M. Immediate contact reactions to benzoic acid and the sodium salt of pyrrolidone carboxylic acid. Contact Dermatitis 1989; 20: 38-40.
150. Fan W, Kinnunen T, Ninimäke A et al. Skin reactions to glycols used in dermatological and cosmetic vehicles. Am J Contact Dermat 1991; 2: 181-183.
151. Funk Jo, Maibach HI. Propylene glycol dermatitis: re-evaluation of an old problem. Contact Dermatitis 1994; 31: 236-241.
152. Lodén M, Andersson A-C, Lindberg M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. II. Adverse effects. J Dermatolog Treat 1999; 10: 171-175.
153. Khan SA. Treatment of non-inflammatory dermatoses. A double-blind comparison of 1% hydrocortisone plus 10% urea and 0.05% fluocinonide. Practitioner 1978; 221: 265-267.
154. Almeyda J, Fry L. Controlled trial of the treatment of atopic eczema with a urea-hydrocortisone preparation versus betamethasone 17-valerat. Br J Dermatol 1973; 88: 493-495.
155. Basketter D, Gerberick F, Kimber I et al. Contact irritation mechanisms. In: Anderson D, Waters MD, Marrs TC, eds. Toxicology of Contact Dermatitis. Allergy, Irritancy and Urticaria. John Wiley and Sons, London, 1999: 11-38.
156. Blank IH. Factors which influence the water content of the stratum corneum. J Invest Dermatol 1952; 18: 433-440.
157. Tsai TF, Maibach HI. How irritant is water? An overview. Contact Dermatitis 1999; 41: 311-314.
158. Tupker RA, Willis C, Berardesca E et al. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997; 37: 53-69.
159. Aungst BJ. The influence of fatty acids and fatty alcohols on skin permeability. In: Lodén M, Maibach HI, eds. Dry Skin and Moisturizers: Chemistry and Function. CRC Press, Boca Raton, 2000: 299-325.
160. Donbrow M, Azaz E, Pillersdort A. Auto-oxidation of polysorbates. J Pharm Sci 1978; 67: 1676-1681.
161. Loden M, Buraczewska I, Edlund F. The irritation potential and reservoir effect of mild soaps. Contact Dermatitis 2003; 49: 91-96.
162. Lodén M, Buraczewska I, Edlund F. Irritation potential of shower oils before and after use. Br J Dermatol 2004; 150: 1142-1147.
163. De Groot AC. Sensitizing substances. In: Lodén M, Maibach HI, eds. Dry Skin and Moisturizers: Chemistry and Function. CRC Press, Boca Raton, 2000: 403-411.
164. Barany E, Lodén M. Content of fragrance mix ingredients and customer complaints of cosmetic products. Am J Contact Dermat 2000; 11: 74-79.
165. Jansson T, Lodén M. Strategy to decrease the risk of adverse effects of fragrance ingredients in cosmetic products. Am J Contact Dermat 2001; 12: 166-169.
166. Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003. Amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. In: Official Journal of the European Union 2003; 66: 27-35.
167. Howlett S. Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999; 140: 381-384.
168. Schlagel CA, Sanborn EC. The weights of topical preparations required for total and partial body inunction. J Invest Dermatol 1964; 42: 253-256.
169. Lynfield YL, Schechter BA. Choosing and using a vehicle. J Am Acad Dermatol 1984; 10: 56-59.
170. Ivens UI, Steinkjer B, Serup J et al. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001; 145: 264-267.
171. Rhodes LE, Diffey BL. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents. Br J Dermatol 1997; 136: 12-17.
172. Johnson R, Nusbaum BP, Horwitz SN et al. Transfer of topically applied tetracycline in various vehicles. Arch Dermatol 1983; 119: 660-663.